WAY-100635 is a potent dopamine D4 receptor agonist

被引:0
作者
Benjamin R. Chemel
Bryan L. Roth
Blaine Armbruster
Val J. Watts
David E. Nichols
机构
[1] Purdue University,Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences
[2] Psychiatry,Departments of Biochemistry
[3] Neurosciences and NIMH Psychoactive Drug Screening Program,undefined
[4] Case Western Reserve University Medical School,undefined
来源
Psychopharmacology | 2006年 / 188卷
关键词
WAY-100635; WAY-100634; 5-HT; D; D; Receptor selectivity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:244 / 251
页数:7
相关论文
共 45 条
[21]   Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-11C]WAY-100635 -: considerations on the validity of cerebellum as a reference region [J].
Hirvonen, Jussi ;
Kajander, Jaana ;
Allonen, Topias ;
Oikonen, Vesa ;
Nagren, Kjell ;
Hietala, Jarmo .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (01) :185-195
[22]   Two C-Methyl Derivatives of [11C]WAY-100635 – Effects of an Amido α-Methyl Group on Metabolism and Brain 5-HT1A Receptor Radioligand Behavior in Monkey* [J].
Julie A. McCarron ;
Sandrine Marchais-Oberwinkler ;
Victor W. Pike ;
Jari Tarkiainen ;
Christer Halldin ;
Judit Sóvagó ;
Balàzs Gulyas ;
Hakan V. Wikström ;
Lars Farde .
Molecular Imaging and Biology, 2005, 7 :209-219
[23]   Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties [J].
Assie, MB ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) :15-21
[24]   Two C-methyl derivatives of [11C]WAY-100635 -: Effects of an amido α-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey [J].
McCarron, JA ;
Marchais-Oberwinkler, S ;
Pike, VW ;
Tarkiainen, J ;
Halldin, C ;
Sóvagó, J ;
Gulyas, BZ ;
Wikström, HV ;
Farde, L .
MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (03) :209-219
[25]   The effects of A 5-HT1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: a microdialysis study with flesinoxan and WAY 100635 [J].
Fokko Bosker ;
Dorien Vrinten ;
André Klompmakers ;
H. Westenberg .
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 355 :347-353
[26]   Quantification of the radio-metabolites of the serotonin-1A receptor radioligand [carbonyl-11C]WAY-100635 in human plasma: An HPLC-assay which enables measurement of two patients in parallel [J].
Nics, L. ;
Hahn, A. ;
Zeilinger, M. ;
Vraka, C. ;
Ungersboeck, J. ;
Haeusler, D. ;
Hartmann, S. ;
Wagner, K-H. ;
Lanzenberger, R. ;
Wadsak, W. ;
Mitterhauser, M. .
APPLIED RADIATION AND ISOTOPES, 2012, 70 (12) :2730-2736
[27]   Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia [J].
Richard M. Kostrzewa ;
Przemysław Nowak ;
Ryszard Brus ;
Russell W. Brown .
Neurochemical Research, 2016, 41 :183-192
[28]   The agranular and granular insula differentially contribute to gambling-like behavior on a rat slot machine task: effects of inactivation and local infusion of a dopamine D4 agonist on reward expectancy [J].
P. J. Cocker ;
M. Y. Lin ;
M. M. Barrus ;
B. Le Foll ;
C. A. Winstanley .
Psychopharmacology, 2016, 233 :3135-3147
[29]   Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats [J].
Kehong Zhang ;
Frank I Tarazi ;
Ross J Baldessarini .
Neuropsychopharmacology, 2001, 25 :624-632
[30]   Antidepressant-Like Effect of D2/3 Receptor-, but not D4 Receptor-Activation in the Rat Forced Swim Test [J].
Ana M Basso ;
Kelly B Gallagher ;
Natalie A Bratcher ;
Jorge D Brioni ;
Robert B Moreland ;
Gin C Hsieh ;
Karla Drescher ;
Gerard B Fox ;
Michael W Decker ;
Lynne E Rueter .
Neuropsychopharmacology, 2005, 30 :1257-1268